55.61
price down icon0.77%   -0.43
after-market Dopo l'orario di chiusura: 55.79 0.18 +0.32%
loading
Precedente Chiudi:
$56.04
Aprire:
$55.6
Volume 24 ore:
17.69M
Relative Volume:
1.08
Capitalizzazione di mercato:
$188.53B
Reddito:
$45.44B
Utile/perdita netta:
$16.18B
Rapporto P/E:
15.30
EPS:
3.634
Flusso di cassa netto:
$9.21B
1 W Prestazione:
-9.43%
1M Prestazione:
+0.49%
6M Prestazione:
-22.47%
1 anno Prestazione:
-55.26%
Intervallo 1D:
Value
$54.56
$56.02
Intervallo di 1 settimana:
Value
$54.56
$61.12
Portata 52W:
Value
$45.05
$121.34

Novo Nordisk Adr Stock (NVO) Company Profile

Name
Nome
Novo Nordisk Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
78,387
Name
Cinguettio
@novonordisk
Name
Prossima data di guadagno
2024-12-06
Name
Ultimi documenti SEC
Name
NVO's Discussions on Twitter

Confronta NVO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
55.61 249.01B 45.44B 16.18B 9.21B 3.634
Drug Manufacturers - General icon
LLY
Lilly Eli Co
724.54 640.60B 53.26B 13.80B -50.20M 15.30
Drug Manufacturers - General icon
JNJ
Johnson Johnson
179.71 428.03B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
220.61 386.06B 58.33B 3.73B 18.24B 2.10
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
123.65 236.62B 53.40B 13.68B 16.89B 6.9231
Drug Manufacturers - General icon
MRK
Merck Co Inc
78.56 193.83B 63.43B 16.42B 14.72B 6.49

Novo Nordisk Adr Stock (NVO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-17 Aggiornamento Berenberg Hold → Buy
2025-09-16 Aggiornamento Rothschild & Co Redburn Neutral → Buy
2025-09-09 Aggiornamento Bernstein Mkt Perform → Outperform
2025-08-13 Aggiornamento BNP Paribas Exane Underperform → Neutral
2025-08-05 Downgrade UBS Buy → Neutral
2025-07-31 Downgrade HSBC Securities Buy → Hold
2025-07-30 Downgrade Barclays Overweight → Equal Weight
2025-04-17 Downgrade BMO Capital Markets Outperform → Market Perform
2025-03-13 Aggiornamento Kepler Hold → Buy
2025-03-03 Downgrade Stifel Buy → Hold
2025-02-12 Iniziato Morgan Stanley Equal-Weight
2025-01-06 Aggiornamento Bernstein Underperform → Mkt Perform
2024-05-30 Iniziato Goldman Buy
2024-04-12 Iniziato BMO Capital Markets Outperform
2024-01-23 Iniziato Morgan Stanley Overweight
2024-01-16 Ripresa UBS Neutral
2023-12-01 Iniziato Cantor Fitzgerald Overweight
2023-10-02 Iniziato Argus Buy
2023-07-14 Iniziato HSBC Securities Buy
2022-07-15 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2022-06-28 Downgrade UBS Neutral → Sell
2022-06-27 Aggiornamento Exane BNP Paribas Underperform → Neutral
2022-06-07 Aggiornamento JP Morgan Neutral → Overweight
2022-05-31 Aggiornamento Guggenheim Neutral → Buy
2022-04-25 Aggiornamento Cowen Market Perform → Outperform
2022-04-12 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2022-03-16 Aggiornamento Deutsche Bank Hold → Buy
2022-01-25 Downgrade Liberum Hold → Sell
2021-12-20 Downgrade JP Morgan Overweight → Neutral
2021-12-17 Downgrade Deutsche Bank Buy → Hold
2021-01-20 Downgrade Credit Suisse Outperform → Neutral
2021-01-15 Iniziato Deutsche Bank Buy
2020-09-29 Iniziato Berenberg Hold
2020-07-06 Downgrade BofA Securities Buy → Neutral
2020-05-11 Downgrade UBS Buy → Neutral
2020-05-04 Iniziato Cowen Market Perform
2020-03-16 Aggiornamento BofA/Merrill Neutral → Buy
2020-01-03 Downgrade Guggenheim Buy → Neutral
2019-11-18 Aggiornamento Barclays Equal Weight → Overweight
2019-09-17 Aggiornamento Citigroup Neutral → Buy
2019-08-30 Downgrade Jefferies Hold → Underperform
2019-06-20 Downgrade Deutsche Bank Buy → Hold
2019-06-11 Aggiornamento Barclays Underweight → Equal Weight
2019-04-29 Aggiornamento Credit Suisse Neutral → Outperform
2019-01-29 Iniziato Exane BNP Paribas Outperform
2018-12-11 Ripresa Jefferies Hold
2018-10-09 Iniziato Guggenheim Buy
2017-12-29 Aggiornamento JP Morgan Underweight → Neutral
2017-12-06 Aggiornamento BofA/Merrill Neutral → Buy
2017-12-01 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2017-09-25 Downgrade Exane BNP Paribas Outperform → Neutral
2017-09-06 Aggiornamento BofA/Merrill Underperform → Neutral
Mostra tutto

Novo Nordisk Adr Borsa (NVO) Ultime notizie

pulisher
02:58 AM

Novo Nordisk ADR earnings missed, revenue topped estimates By Investing.com - Investing.com Nigeria

02:58 AM
pulisher
Sep 27, 2025

Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet? - The Motley Fool

Sep 27, 2025
pulisher
Sep 27, 2025

Novo Nordisk ADR earnings missed, revenue topped estimates - Investing.com India

Sep 27, 2025
pulisher
Sep 24, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming DeadlinesNVO | FinancialContent - FinancialContent

Sep 24, 2025
pulisher
Sep 24, 2025

NVO Stock Quote Price and Forecast - CNN

Sep 24, 2025
pulisher
Sep 23, 2025

NVO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important September 30 Deadline in Securities Class Action - GlobeNewswire Inc.

Sep 23, 2025
pulisher
Sep 20, 2025

NVO IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important September 30 Deadline in Securities Class Action - GlobeNewswire Inc.

Sep 20, 2025
pulisher
Sep 19, 2025

Tools to assess Novo Nordisk A s (b Shares) Adrhedged’s risk profileJuly 2025 Setups & Technical Pattern Based Buy Signals - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Novo Nordisk And Prudential Stand Out In European ADR Gains - Finimize

Sep 18, 2025
pulisher
Sep 18, 2025

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs - Sahm

Sep 18, 2025
pulisher
Sep 18, 2025

Custom strategy builders for tracking Novo Nordisk A s (b Shares) AdrhedgedStock Surge & AI Forecasted Entry/Exit Points - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Novo Nordisk's Wegovy Outperforms Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke, And Death: Study - Sahm

Sep 18, 2025
pulisher
Sep 17, 2025

How Do Investors Really Feel About Novo Nordisk? - Sahm

Sep 17, 2025
pulisher
Sep 17, 2025

NVO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important September 30 Deadline in Securities Class Action - GlobeNewswire Inc.

Sep 17, 2025
pulisher
Sep 17, 2025

Live market analysis of Novo Nordisk A s (b Shares) AdrhedgedInsider Buying & Comprehensive Market Scan Insights - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Published on: 2025-09-17 04:52:55 - newser.com

Sep 17, 2025
pulisher
Sep 17, 2025

Advanced analytics toolkit walkthrough for Novo Nordisk A s (b Shares) AdrhedgedGap Down & AI Powered Trade Plan Recommendations - newser.com

Sep 17, 2025
pulisher
Sep 15, 2025

Price momentum metrics for Novo Nordisk A s (b Shares) Adrhedged explainedMarket Growth Review & AI Driven Price Forecasts - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Highlights: Is Novo Nordisk A s (b Shares) Adrhedged forming a bullish divergenceWeekly Investment Report & Entry Point Confirmation Alerts - khodrobank.com

Sep 15, 2025
pulisher
Sep 15, 2025

Targets Report: Is Novo Nordisk A s b Shares Adrhedged stock heavily shorted2025 Pullback Review & Fast Entry Momentum Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Risk Report: Can Novo Nordisk A s b Shares Adrhedged be the next market leaderWeekly Trade Review & Technical Buy Zone Confirmation - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

What's Going On With Novo Nordisk Shares Monday? - Sahm

Sep 15, 2025
pulisher
Sep 14, 2025

ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Sep 14, 2025
pulisher
Sep 13, 2025

Is the Market Bullish or Bearish on Novo Nordisk? - Sahm

Sep 13, 2025
pulisher
Sep 11, 2025

Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - GlobeNewswire Inc.

Sep 11, 2025
pulisher
Sep 11, 2025

Emmy Award Success for Passion and Robert Valleys 400 Boys Episode in Netflixs Love, Death and Robots - DLH.net

Sep 11, 2025
pulisher
Sep 10, 2025

Novo Nordisk To Cut 9,000 Jobs As Competition From Eli Lilly Heats Up: Analyst Calls Move 'Tough, Natural...Very Necessary' - Sahm

Sep 10, 2025
pulisher
Sep 09, 2025

Teva Pharmaceutical ADR Trying To Close In On Key Technical Measure - Investor's Business Daily

Sep 09, 2025
pulisher
Sep 06, 2025

NOVO_B Stock Price and Chart — OMXCOP:NOVO_B - TradingView

Sep 06, 2025
pulisher
Sep 03, 2025

ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Sep 03, 2025

Novo Nordisk Adr Azioni (NVO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general MRK
$78.56
price up icon 1.24%
$272.98
price up icon 0.66%
$112.10
price up icon 1.00%
drug_manufacturers_general PFE
$23.76
price up icon 0.68%
drug_manufacturers_general NVS
$123.65
price up icon 1.16%
Capitalizzazione:     |  Volume (24 ore):